Company description

The number of tissue samples increases with a growing population, higher average life expectancy, and new individualised treatment methods. This requires increasingly specific analytical responses. At the same time, the healthcare capacity is limited, resulting in longer response times after samples are taken. In parallel, there is a great need to digitise the analysis processes, otherwise known as, digital pathology.

The level of accuracy based on today’s staining methods in tissue diagnostics is about 70%, which means that about 30% of pathologists’ opinions are incorrect or uncertain, which emphasises a strong need for increased accuracy.

With Lumito’s unique and patented technology, there are provisions to significantly improve the diagnostics for tissue samples through shorter analytical times and higher quality analysis. Lumito’s technology also provides completely new opportunities to search for multiple disease indications in the same tissue section.

History

The company was formed in 2010 and is another spin-off from the research group at the Department of Nuclear Physics at Lund Laser Centre, which has been led by Professor Stefan Andersson-Engels for a long time. Lumito can thus turn to a range of companies that have sprouted and grown from this research environment; Gasoptics Sweden AB and SpectraCure AB to name just two. The company is based on many years of work by the research team’s world-leading research in the field. After trying at an early stage to commercialise the technique through a business model based on licensing technology, the Company decided to take the technology to the market by developing its own Digital Pathology products.

Lumito's Board

MASOUD KHAYYAMI, CHAIRMAN
Doctor of Biochemistry at Lund University.

BG SVENSSON,
BOARD MEMBER
Master in Business Administration and Economics, Lund University.

PROF. STEFAN ANDERSSON-ENGELS, BOARD MEMBER
Technology Doctor of Physics, 1990, Lund University.

URBAN WIDÉN, BOARD MEMBER


Lumito's senior executives

STEFAN NILSSON, CEO
Master of Science in Electrical Engineering, Lund University.

ANDERS SJÖGREN, CTO
Master of Science and PhD, Lund University.

HENRIK LJUNG, CFO
Master in Business Administration and Economics, Lund University


Auditor

Berit Holmgren
Carlsson & Partners Revisionsbyrå AB
Drottninggatan 99
113 60 Stockholm
Telefon: 08-458 92 50

www.carlrev.se

Research group and inventor

Listed below are the people who have most been involved in the research and inventions that have led to the Company being what it is today:

Stefan Andersson-Engels; Professor of Biophotonics at both the Medical Laser Centre and the Department of Physics, both at Lund University. Internationally known for research on UCNP, Stefan Andersson-Engels is a partner and board member of the Company.

Former and current PhD students to Stefan Andersson-Engels:

  • Johan Axelsson; PhD in laser physics with a focus on biophotonics
  • Haichun Liu; PhD in laser physics with a focus on UCNP, (now a researcher at KTH in Stockholm)
  • Monirehalsalat Mousavi; doctoral student with a focus on biophotonics at the Medical Laser Centre and the Department of Physics
  • Pontus Svenmarker; PhD in laser physics with a focus on biophotonics
  • Can Xu; PhD in laser physics with a focus on UCNP, (now CTO at Norsk Elektro Optikk Lund AB)

Anders Sjögren; PhD in laser physics, CTO in the Company

Urban Widén; board member of the Company.

Scientific Advisors

Get in touch with Lumito

Lumito AB
SE-226 43 Lund, Sweden

+46(0)46-16 20 70
info@lumito.se

Reg. No: 556832-0062
VAT No: SE556832006201

Besöksadress

Magistratsvägen 10
SE-226 43 Lund, Sweden

Postadress

Magistratsvägen 10
SE-226 43 Lund, Sweden

Business & Administration

Stefan Nilsson
CEO
sn@lumito.se